These single-cell transcriptomic analyses further substantiate the mechanistic model by revealing that THOC1 upregulation aligns with heightened SIN3A–HDAC1/2 scaffold activity across patient-derived GBM cells. This evidence concerns the gene SIN3A and glioblastoma.